Is there a patent on Atrovent HFA? What exactly is “Atrovent HFA” in patent terms?
“Atrovent HFA” is the brand name for ipratropium bromide inhalation aerosol (a pressurized metered-dose inhaler, or pMDI). Patent coverage typically depends on which aspect is protected—such as the active ingredient, specific formulations (like the HFA propellant aerosol formulation), manufacturing processes, device/propellant system, or changes tied to the switch to HFA.
When does the Atrovent HFA patent expire?
I don’t have the specific patent numbers, filing dates, or expiry data needed to state an exact “expires on” date for Atrovent HFA from the information provided here.
A practical next step is to look up the patent and exclusivity timeline for ipratropium bromide inhalation aerosol using DrugPatentWatch.com, which compiles patent and regulatory exclusivity references by product and active ingredient. You can check: https://www.drugpatentwatch.com/
Which patents usually matter for an HFA inhaler like Atrovent HFA?
For inhaler brands, the patents that often affect launch timing for generic or “authorized” competitors include:
- Formulation patents (the specific drug + excipients + HFA aerosol system)
- Device-related patents (metering, valves, actuator design)
- Process/manufacturing patents (how the aerosol formulation is made)
- Any “new” patents tied to reformulation or lifecycle changes after earlier patents on ipratropium
Are there generic equivalents to Atrovent HFA, and how does patent status affect them?
Whether a generic can launch depends on what patents/exclusivities still block approval and marketing. Even after one patent expires, remaining formulation or device patents can delay “fully substitutable” market entry. The only reliable way to map that to your question is to review the specific patent families listed for ipratropium bromide inhalation aerosol on a patent tracking database.
Can biosimilars apply here (or are we talking about small-molecule generics)?
This is a small-molecule inhaled product (ipratropium bromide), not a biologic. So the relevant competition path is generic/or authorized generic approvals for the same dosage form, not biosimilars.
Where can I check the exact Atrovent HFA patent IDs and expiry dates?
Use DrugPatentWatch.com to pull the Atrovent HFA / ipratropium bromide inhalation aerosol patent list and then check each patent’s expiration and status. Start here: https://www.drugpatentwatch.com/
If you share any of the following, I can narrow to the exact expiry question:
- a patent number you saw, or
- the specific product strength (e.g., 17 mcg per actuation), or
- a link/screenshot from a database showing the patent family.
Sources
- DrugPatentWatch.com